Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
Andres-Ejarque R, Ale HB, Grys K, Tosi I, Solanky S, Ainali C, Catak Z, Sreeneebus H, Saklatvala J, Dand N, de Rinaldis E, Chapman A, Nestle FO, Barnes MR, Warren RB, Reynolds NJ, Griffiths CEM, Barker JN, Smith CH, Di Meglio P; PSORT Consortium.
Andres-Ejarque R, et al. Among authors: di meglio p.
Nat Commun. 2021 Dec 16;12(1):7358. doi: 10.1038/s41467-021-27447-6.
Nat Commun. 2021.
PMID: 34916493
Free PMC article.
No abstract available.